Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
03/2003
03/18/2003CA2422709A1 Substituted cinnamic acid guanidides, method for the production thereof,their use as a medicament, and to a medicament containing these compounds
03/18/2003CA2244501C Arylsulfonylamino hydroxamic acid derivatives
03/18/2003CA2162708C Bicyclic amide derivatives and their use as muscle relaxants
03/13/2003WO2003020688A1 Selective protein tyrosine phosphatase inhibitors
03/13/2003WO2003020686A2 Method for producing 4-amino-1-naphthol ethers
03/13/2003WO2003020287A2 Methods for the treatment of chronic pain anc compositions therefor
03/13/2003WO2003020029A1 Arylamines as inhibitors of chemokine binding to us28
03/13/2003WO2003004472A8 Arylamines for the treatment of conditions associated with gsk-3
03/13/2003WO2002097050A3 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions
03/13/2003WO2002066469A3 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
03/13/2003WO2002050019A3 Diamines as modulators of chemokine receptor activity
03/13/2003WO2002046149A3 2-thio-5-amino substituted benzoquinones, their manufacture and their use in rubber
03/13/2003WO2002036554A3 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
03/13/2003US20030050507 Method for prepararing alkoxyamines from nitroxides
03/13/2003US20030050338 Novel interleukin-1 and tumor necrosis factor-alpha modulators, synthesis of said and their enantimoners and methods of using said modulators
03/13/2003US20030050316 An amine compound of phenyl or hetero ring for treating Alzheimer's disease
03/13/2003US20030050310 Hydroxamic acid derivatives as proteinase inhibitors
03/13/2003US20030050299 An intermediates for enantiomeric synthesis cermamide-like inhibitors; producing antilipemic agents
03/13/2003US20030050298 A sulfonamide substituted diphenyl thiourea compounds treating a chemokine mediated disease
03/13/2003US20030049310 Genetic enginnering; inducing antibodies
03/12/2003EP1289972A1 Serine protease inhibitors
03/12/2003EP1289971A1 Benzamide derivatives and their use as apob-100 and mtp inhibitors
03/12/2003EP1289944A2 Thioketals and thioethers for inhibiting the expression of vcam-1
03/12/2003EP1289935A1 Excitatory amino acid receptor modulators
03/12/2003EP1289500A1 Novel pharmaceutical formulation suitable for nebulisation
03/12/2003EP1086073B1 Method for preparing alkoxyamines from nitroxides
03/12/2003EP1036058B1 Adamantane derivatives
03/12/2003EP0977730B1 Amino acid derivatives inhibiting extracellular matrix metalloproteinase and tnf alpha release
03/12/2003EP0874830B1 A metalloproteinase inhibitor, a pharmaceutical composition containing it and the pharmaceutical use and method useful for the preparation thereof
03/12/2003CN1401639A Process for synthesis of azacyclic compounds
03/11/2003US6531610 Intermediate acylating carbonate
03/11/2003US6531604 Useful as medicines having an osteogenesis promoting effect and chondrogensis promoting effect.
03/11/2003US6531472 Tetralone derivatives
03/07/2003WO2002020472A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
03/07/2003CA2421781A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
03/06/2003WO2003019697A2 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives
03/06/2003WO2003018549A2 Bicyclic compounds as inhibitors of chemokine binding to us28
03/06/2003WO2003018543A1 Novel cyclohexyl sulphones
03/06/2003WO2003018538A1 Novel diarylalkene derivatives and novel diarylalkane derivatives
03/06/2003WO2003018535A2 Novel aminobenzoephenones
03/06/2003WO2003017998A1 Platinum complexes and their use in cancer treatment
03/06/2003WO2003017995A1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluropropanamide derivatives which elevate pyruvate dehydrogenase activity
03/06/2003WO2003017948A2 Aryl tetrahydronaphthalene derivatives
03/06/2003WO2003017764A1 Substituted propargylamines
03/06/2003WO2002102381A9 Acylic piperazine and piperidine derivatives which are useful for treating neuronal damage
03/06/2003WO2002100844A3 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/06/2003WO2002070470A3 Benzophenones as inhibitors of reverse transcriptase
03/06/2003WO2002066415A8 Non-steroidal modulators of estrogen receptors
03/06/2003US20030045712 Substituted aryl and heteroaryl derivatives, the preparation thereof and the use therof as pharmaceutical compositions
03/06/2003US20030045581 4-substituted-1- (arylmethylidene) thiosemicarbazide, 4-substituted-1- (arylcarbonyl) thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof
03/06/2003US20030045579 Compounds and compositions for delivering active agents
03/06/2003US20030045556 Aryl-N-cyanoguanidines and methods related thereto
03/06/2003US20030045530 Administering a piperazine or piperidine coupled through a linker to a benzhydril
03/06/2003US20030045529 Method for specifically potentiating N-type Ca2+ channel activity
03/06/2003US20030045478 Treating diseases such as cardiac and cerebral ischemia or reperfusion injury, sepsis and bacterial meningitis.
03/06/2003CA2458121A1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluropropanamide derivatives which elevate pyruvate dehydrogenase activity
03/06/2003CA2456420A1 Novel cyclohexyl sulphones
03/06/2003CA2456348A1 Platinum complexes and their uses in therapy
03/05/2003EP1288236A2 Production process for copolymers with controlled architecture with the aid of functional radical initiators in a living radical polymerisation
03/05/2003EP1288208A1 Process for the preparation of 2-(4-Alkyl-1-Piperazinyl)-Benzaldehyde and -Benzylidenyl compounds by Nucleophilc Aromatic Substitution of 2-Fluorobenzaldehyde with 4-Alkyl-1-Piperazine in Water as Solvent
03/05/2003EP1286997A1 6-phenylpyrrolopyrimidinedione derivatives
03/05/2003EP1286978A1 Cyclohexyl derivatives and their use as therapeutic agents
03/05/2003EP1286977A1 A new process for the synthesis of morpholinylbenzenes
03/05/2003EP1286967A1 Cyclohexane derivatives and their use as therapeutic agents
03/05/2003EP1286953A1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
03/05/2003EP1286670A2 Use of therapeutic benzamide derivatives
03/05/2003EP1127061B1 Chiral ligands for asymmetric catalysis
03/05/2003EP1019368B1 Acylsulfamoyl benzoic acid amides, plant protection agents containing said acylsulfamoyl benzoic acid amides, and method for producing the same
03/05/2003EP1012134B1 Quaternary ammonium phosphate compounds and method of preparing the same
03/05/2003EP0939628B1 Thiol sulfone metalloprotease inhibitors
03/05/2003CN1400969A Fused imidazolium derivatives
03/05/2003CN1400505A Image forming material and ammonium compound
03/04/2003US6528678 Phosgene-free process for preparing carbamates
03/04/2003US6528675 Cyanohydrin ethers and esters as high-sensitivity enzyme substrates
03/04/2003US6528647 Process for the synthesis of an aliphatic cyclic amine
03/04/2003US6528529 Compounds with activity on muscarinic receptors
03/04/2003US6528525 Amidocarboxylic acid derivatives
03/04/2003CA2218913C Substituted oximes, hydrazones and olefins as neurokinin antagonists
02/2003
02/28/2003CA2399970A1 Process for the preparation of 2-(4-alkyl-1-piperazinyl)-benzaldehyde and -benzylidenyl compounds
02/27/2003WO2003016270A2 Selective estrogen receptor modulators
02/27/2003WO2003015775A1 New dipeptidyl peptidase iv inhibitors and their uses for lowering blood pressure levels
02/27/2003WO2003015761A1 Selective estrogen receptor modulators
02/27/2003WO2003000181A3 Dipeptidyl peptidase inhibitors for the treatment of diabetes
02/27/2003WO2002096884A3 Substituted benzoylketones as herbicidal agents for use as plant treatment agent
02/27/2003WO2002089749A3 Arylsulfonamide ethers, and methods of use thereof
02/27/2003WO2002012149A3 Method for preparing alkoxyamines from nitroxides
02/27/2003CA2456150A1 Selective estrogen receptor modulators
02/27/2003CA2423025A1 New dipeptidyl peptidase iv inhibitors and their uses for lowering blood pressure levels
02/26/2003EP1285911A2 Arylsulfonanilide ureas
02/26/2003EP1285651A1 Melanin concentrating hormone antagonists
02/26/2003EP1284730A1 Aralkyl ester soft drugs
02/26/2003EP1284722A2 Compositions containing a benzamide disulfide derivative for treating allergic diseases
02/26/2003EP0938483B1 Muscarinic antagonists
02/26/2003CN1399639A New oxabispidine compound useful in treatment of cardiac arrhythmias
02/26/2003CN1399622A Triphenylalkene derivatives and their use as selective estrogen receptor modulators
02/25/2003US6525215 HIV protease inhibitors
02/25/2003US6525199 Ring coupling, reduction and deprotecting; synthesis of compounds for alleviation and treatment of symptoms due to ischemic diseases
02/25/2003US6525099 N-substituted sulfonamide derivatives
02/25/2003US6525070 Bipiperidine derivatives as modulators of CCR3 activity and as H1 antagonists
02/25/2003US6525068 Hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand
1 ... 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 ... 341